bioAffinity Technologies (BIAF) Cash from Operations (2021 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Cash from Operations of 3227240.0 for Q1 2026, down 96.57% year-over-year from 94093446.12 in Q1 2025, and down 26.09% quarter-over-quarter from 2559563.0 in Q4 2025.
bioAffinity Technologies (BIAF) Cash from Operations (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Cash from Operations for 6 consecutive years, with 3227240.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 96.57% year-over-year to 3227240.0; the TTM figure through Mar 2026 stood at 10914307.0 (down 66.36% YoY), while the FY2025 annual figure was 9328842.0, down 28.41% from the prior year.
- Cash from Operations eased to 3227240.0 in Q1 2026 per BIAF's latest filing, from 2559563.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 376141.0 in Q2 2022 and bottomed at 3227240.0 in Q1 2026.
- Historically, Cash from Operations has averaged 1760560.47 across 5 years, with a median of 1641775.0 in 2025.
- Annual changes were most pronounced in 2023 — Cash from Operations plunged 261.55% — and 2025, when it jumped 30.02%.
- bioAffinity Technologies' Cash from Operations stood at 1300636.0 in 2022, then dropped by 24.27% to 1616303.0 in 2023, then slipped by 3.77% to 1677161.0 in 2024, then plunged by 52.61% to 2559563.0 in 2025, then fell by 26.09% to 3227240.0 in 2026.
- Business Quant data shows BIAF's Cash from Operations at 3227240.0 in Q1 2026, 2559563.0 in Q4 2025, and 2480298.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 2.13 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 1.53 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 54.79 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 277.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 558.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 347.16 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 201.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 310.42 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 445.50 Mn |
| 10 | bioAffinity Technologies | 1.78 Mn | -649,139.45 | - | -3.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.20 Mn |
| Jun 30, 2026 | -3.20 Mn |
| Mar 31, 2026 | -3.23 Mn |
| Mar 31, 2026 | -3.23 Mn |
| Dec 31, 2025 | -2.56 Mn |
| Dec 31, 2025 | -2.56 Mn |
| Sep 30, 2025 | -2.48 Mn |
| Sep 30, 2025 | -2.48 Mn |
| Jun 30, 2025 | -2.65 Mn |
| Jun 30, 2025 | -2.65 Mn |
| Mar 31, 2025 | -1.64 Mn |
| Mar 31, 2025 | -1.64 Mn |
| Dec 31, 2024 | -1.68 Mn |
| Dec 31, 2024 | -1.68 Mn |
| Sep 30, 2024 | -1.71 Mn |
| Sep 30, 2024 | -1.71 Mn |
| Jun 30, 2024 | -1.53 Mn |
| Jun 30, 2024 | -1.53 Mn |
| Mar 31, 2024 | -2.35 Mn |
| Mar 31, 2024 | -2.35 Mn |